Article

Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed…

bioRxiv: the preprint server for biology · 2023 · Tetsuya Inoue, author Yuichiro Yamamoto, author Kaoru Sato, author Yuko Nakamura, author Yoshimi Shimizu, author Motohiko Ogawa, author Taishi Onodera, author Yoshimasa Takahashi, author Takaji Wakita, author Mika K. Kaneko, author Masayoshi Fukasawa, author Yukinari Kato, author Kohji Noguchi, author

Key facts

Title Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
First author Tetsuya Inoue, author Yuichiro Yamamoto, author Kaoru Sato, author Yuko Nakamura, author Yoshimi Shimizu, author Motohiko Ogawa, author Taishi Onodera, author Yoshimasa Takahashi, author Takaji Wakita, author Mika K. Kaneko, author Masayoshi Fukasawa, author Yukinari Kato, author Kohji Noguchi, author
Journal bioRxiv : the preprint server for biology
Published Nov 1, 2023
DOI 10.1101/2023.10.26.564289
Devices mentioned K001005, K030065, K030320, K042152, K042550, K100464, K810863, K871763, K940422, K954145, K960874, K963847 and 5 more
Product codes mentioned CFN, DAE, DBM, DFZ, JIS, JIT, JIX, JJX, JLX, KQP, MRR, NSF and 10 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature